Press Releases

Intensity Therapeutics Recognizes Rare Disease Day 2019

Feb 25 2019

Intensity Therapeutics, Inc. joins patients, caregivers and rare disease advocates worldwide to recognize Rare Disease Day 2019, which is February 28. The main objective of the day is to raise public awareness of rare diseases, which are often severely debilitating illnesses that have a dramatic impact on patients’ lives. “Unfortunately, such diseases do not receive… Read more »

Intensity Therapeutics to Participate in Panel at 2019 BIO CEO & Investor Conference

Feb 25 2019

Intensity Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary technology and products to kill tumors and increase immune cell recognition of solid tumor cancers, today announced that Lewis H. Bender, President and CEO, will participate in the “Reshaping Tumor Microenvironments via Immunotherapies” panel at the 2019 BIO CEO & Investor Conference. The panel will examine… Read more »

Intensity Therapeutics Strengthens Intellectual Property Portfolio with Issuance of Several New Patents in Asia and Australia

Dec 25 2018

Intensity Therapeutics, Inc., a clinical-stage biotechnology company developing proprietary technology and products to kill tumors and increase immune cell recognition of solid tumor cancers, today announced the receipt of patents protecting the Company’s technology and its lead product candidate, INT230-6, in China, Japan, Korea, Russia and Australia. All five countries have granted the Company a… Read more »

View All Press Releases

Publications/Papers/Posters

SITC 2018 Poster Presentation P622

Phase 1/2 Evaluation of Intratumoral INT230-6 for the Treatment of Solid Tumors

ESMO 2018 Poster Presentation Abstract 4458

Phase 1/2 Evaluation of Intratumoral INT230-6 for the Treatment of Solid Tumors

ASCO 2018 Poster Presentation TPS2609

Phase 1/2 trial evaluating intratumoral administration of INT230-6 alone and in combination with an anti-PD1 antibody for advanced malignancies. TPS2609

View All Publications/Papers/Posters